modelCyanocobalamin_1

Diagram of Cyanocobalamin_1

Extends from Pharmacolibrary.Drugs.ATC.B.B03BA01_1.

Information

name:Cyanocobalamin_1
ATC code:B03BA01_1
route:oral
compartments:1
dosage:1500mg
volume of distribution:3.0L
clearance:3.0mL/min
other parameters in model implementation

Cyanocobalamin is a synthetic form of vitamin B12 used to treat and prevent vitamin B12 deficiency. It is essential for DNA synthesis, red blood cell maturation, and neurological function. It is approved and widely used today.

Pharmacokinetics

Pharmacokinetic parameters after single oral dose in healthy adults.

References

  1. Andres, E, et al., & Weitten, T (2009). [Update of oral vitamin B12]. Annales d'endocrinologie 70(6) 455–461. DOI:10.1016/j.ando.2009.07.001 PUBMED:https://pubmed.ncbi.nlm.nih.gov/19683698

  2. Kurpad, AV, et al., & Devi, S (2023). Bioavailability and daily requirement of vitamin B. The American journal of clinical nutrition 118(6) 1214–1223. DOI:10.1016/j.ajcnut.2023.08.020 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38044024

  3. Sezer, RG, et al., & Özdemir, GN (2018). Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children. Hematology (Amsterdam, Netherlands) 23(9) 653–657. DOI:10.1080/10245332.2018.1456023 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29577819

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)